Legal updates and opinions
News / News
Compensation for employees who experience injuries, illness or death as a result of the Covid-19 vaccine
Compensation for Occupational Injuries and Diseases Act 130 of 1993
by Jacques van Wyk, Director and Andre van Heerden, Senior Associate
On 22 October 2021, a notice was published in the Government Gazette in terms of section 6A(b) of the Compensation for Occupational Injuries and Diseases Act 130 of 1993 (“COIDA“). The notice relates to the compensation for side effects to the Covid-19 vaccination (“Notice“) based on employees who experience injuries, illness or death as a result of the Covid-19 vaccine in the circumstances where the requirement to have the vaccine is an inherent requirement of the employee’s job or where the employee is required to do so in terms of his/her employer’s risk assessment.
Read our article discussing vaccination policies for the workplace for more on the implementation of a mandatory vaccination policy and the required risk assessment).
The Notice provides that if an employee is required to receive a Covid-19 vaccine, either as a result of an occupational health and safety risk assessment conducted by an employer or where the vaccine is an inherent requirement of employment, any injury, illness or death incurred as a result will be covered by the Compensation Fund.
However, in order for such cover to extend to an employee, there are 6 requirements that apply:
- The vaccine must be regarded as an inherent requirement of employment in terms of the employer’s risk assessment;
- The employee must have received a SAHPRA-approved Covid-19 vaccine;
- Evidence of the employer’s risk assessment and vaccination plan in terms of the Consolidated Directions on Occupational Health and Safety Measures in Certain Workplaces must be provided;
- The chronological sequence between the vaccine inoculation and the development of the employee’s symptoms and clinical signs must be provided;
- The employee must have presented with symptoms and clinical signs that are generally recognised as side effects of the Covid-19 vaccine; and
- Additional tests may be required to assess the presence of abnormalities of any organ affected.
A copy of the Notice can be accessed here.
Latest News
Service under court online: what litigants need to know
by Teresa Thomas - Candidate Attorney and reviewed by Walid Brown - Director Gone are the days when a missing [...]
Pricing the same as your competitors – unlawful or permissible?
by Paul Coetser - Director and Head of Competition and Ntombi Nzimande - Associate One often observes in the marketplace [...]
A new Trade Mark Act for Zambia
by Donvay Wegierski - Director and Dannielle Fiff - Senior Associate The Zambian Trade Marks Bill 2023 signed on 31 [...]
Celebrating International Data Privacy Day: “12 years of POPIA – what next?”
by Tebogo Sibidla, Director On 28 January 2026, the global community celebrated International Data Privacy Day. This year, its commemoration [...]
Advertising Regulatory Board ups the ante on responsible gambling advertising
by Wendy Rosenberg Director and Head of Digital Media & Electronic Communications and Nothando Madondo, Associate While gambling advertising is [...]
Excessive delay in disciplinary proceedings could render the dismissal unfair
Lethoba and Rand Water (2025) 46 ILJ 2771 (CCMA) by Andre van Heerden - Director and Mikayla Ehrenreich - Candidate Attorney [...]
